Board of Directors

James R. McNab, Jr.
Chairman of the Board, Curis
Chief Executive Officer and Chairman of Palmetto Pharmaceuticals, Inc.; Executive Chairman of FirstString Research, Inc.

Susan B. Bayh
Director, Dendreon Corporation, Dyax Corporation, Emmis Communications and Wellpoint, Inc.
Formerly Commissioner of the International Commission between the United States and Cananda; Formerly attorney in the Pharmaceutical Division of Eli Lilly and Company

Kenneth I. Kaitin, Ph.D.
Director of the Tufts Center for the Study of Drug Development
Professor of Medicine at Tufts University School of Medicine; Serves on Faculty of European Center for Pharmaceutical Medicine at the University of Basel; Director, Bio-Tree Systems, Inc. and New England Healthcare Institute

Robert Martell, M.D., Ph.D.
Tufts Medical Center Cancer Center and Associate Professor of Medicine at the Tufts University School of Medicine; formerly Chief Medical Officer of MethylGene, Director of Oncology Global Clinical Research at Bristol-Myers Squibb Company

Martyn D. Greenacre
Chairman of BMP Sundstone and Life Mist LLC
Director, Cephalon, Inc. and Acusphere, Inc.

Daniel R. Passeri
President and Chief Executive Officer, Curis, Inc.

Marc Rubin, M.D.
Executive Chairman of Board of Directors, Titan Pharmacueticals
Formerly in executive level positions at Bayer Schering Pharma, Schering AG and GlaxoSmithKline

James R. Tobin
Formerly President and Chief Executive Officer, Boston Scientific Corporation